Inside the research
Coty Inc.
COTY Research profile · latest available data
Price overview
$2.65
▲ +0.02 (+0.8%)
| 52w hi | $4.45 |
|---|---|
| 52w lo | $1.85 |
| Vol | 3.90M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.22
| Short | +0.09 |
|---|---|
| Medium | -0.29 |
| Long | -0.69 |
computed 2026-09-27
Key fundamentals
Coty Inc.
Consumer Defensive · Household & Personal Products
| Market cap | $2.33B |
|---|---|
| Enterprise value | $5.84B |
| Forward P/E | 10.35x |
| EV / EBITDA | 7.38x |
| P / S (ttm) | 0.40x |
| Profit margin | -10.4% |
| Return on equity | -16.1% |
| Revenue growth | +1.3% |
| Debt / equity | 97.54 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.04 | |
| Sector | -0.01 | |
| Technical | -0.03 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products in the United States and internationally. It operates through two segments: Prestige and Consumer Beauty. The company provides fragrances, color cosmetics, and skin and body care products. It offers prestige products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under Burberry, Calvin Klein, Chloe, Davidoff, Escada, Etro, Gucci, Hugo Boss, Infiniment Coty Paris, Jil Sander, Joop!, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Orveda, philosophy, and Tiffany & Co. brands. The company provides beauty products through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, David Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, LeGer by Lena Gercke, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Vera Wang, and Sally Hansen brands. It also sells its products through third-party distributors. Coty Inc. was founded in 1904 and is headquartered in New York, New York. Coty Inc. operates as a subsidiary of JAB Beauty B.V.
Risk Metrics
| Beta vs SPX | 0.98 |
|---|---|
| Corr SPX | 0.31 |
| Annual vol | 50.3% |
| Annual ret | -49.2% |
| Sharpe | -0.98 |
| Max DD | -80.5% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-07 | Other Material Event, Exhibits | read |
| 2026-07-02 | Officer / Director Change, Exhibits | read |
| 2026-05-05 | Earnings Release, Exhibits | read |
| 2026-03-18 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-02-05 | Earnings Release, Exhibits | read |
| 2025-12-22 | Officer / Director Change, Exhibits | read |
| 2025-12-19 | Material Agreement, 2.06… | read |
| 2025-11-12 | Shareholder Vote, Exhibits | read |
| 2025-11-05 | Earnings Release, Exhibits | read |
| 2025-10-15 | Material Agreement, Material Obligation… | read |
| 2025-10-07 | Other Material Event, Exhibits | read |
| 2025-10-02 | Other Material Event, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-04 | Srinivasan Priya | Chief People & Purpose Of | Option exercise | 4.74K | — |
| 2026-04-04 | Srinivasan Priya | Chief People & Purpose Of | Withheld for tax | 2.35K | — |
| 2026-03-06 | von Bretten Gordon | President - Consumer Beau | Buy | 83.00K | $200.29K |
| 2026-02-10 | Mercier Laurent | Chief Financial Officer | Buy | 5.00K | $13.25K |
| 2025-12-18 | Makanju Anna Adeola | Option exercise | 13.29K | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 98.3% |
| HHI | 4,383 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $34.43M | 15.94M |
| AQR Capital Management | $8.15M | 4.12M |
| Capital Research / Capital World | $6.76M | 3.13M |
| Millennium Management | $2.38M | 1.10M |
| Fidelity / FMR LLC | $1.99M | 922.38K |
| Citadel Advisors | $906.83K | 419.83K |
| T. Rowe Price Group | $918 | 424.73K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2014–2025 · 12 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $5.55B | +1.6% | |
| Gross profit | $3.55B | +2.2% | |
| Operating income | $241.10M | -9.4% | |
| Net income | $89.40M | -58.1% | |
| Cash from ops | $625.70M | +0.6% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $2.62 | $2.67 | $2.59 | $2.65 | 3.90M |
| Sep 24 | $2.63 | $2.68 | $2.60 | $2.63 | 4.87M |
| Sep 23 | $2.65 | $2.69 | $2.61 | $2.64 | 4.92M |
| Sep 22 | $2.58 | $2.69 | $2.53 | $2.67 | 5.20M |
| Sep 21 | $2.45 | $2.52 | $2.40 | $2.51 | 4.80M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →